Tokyo Tape
Sign in
← K Pharma

Annual report

4896.TEDINET S100T51H
Period2023-01-01 → 2023-12-31
Filed2024-03-28
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 68
MetricValuePeriodScopeSource row
Revenue¥1.0bn2023-01-01 → 2023-12-31StandaloneNet sales
Operating income¥366m2023-01-01 → 2023-12-31StandaloneOperating income
Operating income−¥354m2022-01-01 → 2022-12-31StandaloneOperating income
Ordinary income¥344m2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income−¥359m2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income−¥221m2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥270m2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥256m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥301m2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax−¥391m2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Net income¥260m2023-01-01 → 2023-12-31StandaloneProfit loss
Net income−¥392m2022-01-01 → 2022-12-31StandaloneProfit loss
Net income−¥229m2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income−¥271m2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥256m2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Total assets¥3.3bnat 2023-12-31StandaloneAssets
Total assets¥1.4bnat 2022-12-31StandaloneAssets
Total assets¥206mat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥57mat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥294mat 2019-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥209mat 2023-12-31StandaloneLiabilities
Total liabilities¥38mat 2022-12-31StandaloneLiabilities
Net assets / equity¥3.1bnat 2023-12-31StandaloneNet assets
Net assets / equity¥1.3bnat 2022-12-31StandaloneNet assets
Net assets / equity¥179mat 2021-12-31dStandaloneNet assets
Net assets / equity¥8mat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥279mat 2019-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥3.3bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥1.3bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥3.3bnat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥189mat 2021-12-31dStandaloneCash and cash equivalents
Operating cash flow¥454m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥363m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥196m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥11m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥33m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥250,0002021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.5bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.5bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥368m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥25.422023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-42.062022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-30.092021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-38,751.132020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-37,032.982019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥23.072023-01-01 → 2023-12-31StandaloneDiluted earnings per share (5-year summary)
Net assets per share¥267.55at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥-122.77at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥-107.03at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥-84,539.31at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥-45,788.18at 2019-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio93.7%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio97.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio86.9%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio14.1%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio95.0%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE11.7%2023-01-01 → 2023-12-31StandaloneRate of return on equity (5-year summary)
Shares issued11,604,600at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued5,000at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued5,000at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued5,000at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued5,000at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees15at 2023-12-31StandaloneNumber of employees
Employees13at 2022-12-31StandaloneNumber of employees
Employees11at 2021-12-31dStandaloneNumber of employees
Employees10at 2020-12-31dStandaloneNumber of employees
Employees9at 2019-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 701
ItemContextValueUnit
Net cash provided by used in investment activitiesPrior1YearDuration_NonConsolidatedMember-32737000JPY
Net cash provided by used in investment activitiesCurrentYearDuration_NonConsolidatedMember-11099000JPY
Proceeds from issuance of common stock fin cfPrior1YearDuration_NonConsolidatedMember1544375000JPY
Proceeds from issuance of common stock fin cfCurrentYearDuration_NonConsolidatedMember1496325000JPY
Going public expenses fin cfPrior1YearDuration_NonConsolidatedMember－JPY
Going public expenses fin cfCurrentYearDuration_NonConsolidatedMember-10000000JPY
Other net fin cfPrior1YearDuration_NonConsolidatedMember-90000JPY
Other net fin cfCurrentYearDuration_NonConsolidatedMember-90000JPY
Net cash provided by used in financing activitiesPrior1YearDuration_NonConsolidatedMember1544285000JPY
Net cash provided by used in financing activitiesCurrentYearDuration_NonConsolidatedMember1486235000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember1148065000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember1929560000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember188782000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1336847000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1336847000JPY
Cash and cash equivalentsCurrentYearInstant_NonConsolidatedMember3266408000JPY
Accumulated depreciation buildingsPrior1YearInstant_NonConsolidatedMember-7534000JPY
Accumulated depreciation buildingsCurrentYearInstant_NonConsolidatedMember-50267000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember-77049000JPY
Accumulated depreciation tools furniture and fixturesCurrentYearInstant_NonConsolidatedMember-85774000JPY
Construction in progressPrior1YearInstant_NonConsolidatedMember8350000JPY
Construction in progressCurrentYearInstant_NonConsolidatedMember－JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember163971000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember255417000JPY
Directors compensations sgaPrior1YearDuration_NonConsolidatedMember50386000JPY
Directors compensations sgaCurrentYearDuration_NonConsolidatedMember69200000JPY
Salaries and allowances sgaPrior1YearDuration_NonConsolidatedMember23874000JPY
Salaries and allowances sgaCurrentYearDuration_NonConsolidatedMember52487000JPY
Commission fee sgaPrior1YearDuration_NonConsolidatedMember41104000JPY
Commission fee sgaCurrentYearDuration_NonConsolidatedMember65361000JPY
Rent expenses sgaPrior1YearDuration_NonConsolidatedMember18162000JPY
Rent expenses sgaCurrentYearDuration_NonConsolidatedMember25513000JPY
Taxes and dues sgaPrior1YearDuration_NonConsolidatedMember20419000JPY
Taxes and dues sgaCurrentYearDuration_NonConsolidatedMember29071000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-03-28
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第７期(自　2023年１月１日　至　2023年12月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社ケイファーマ
Company name in english cover pageFilingDateInstantK Pharma,Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　福島　弘明
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都港区六本木七丁目７番７号
Telephone number address of registered headquarter cover pageFilingDateInstant03-6629-3380
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)常務取締役CFO　松本　真佐人
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都港区六本木七丁目７番７号
Telephone number nearest place of contact cover pageFilingDateInstant03-6629-3380
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)常務取締役CFO　松本　真佐人
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE38985

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-12-31pass rounding
balance sheet identitynon_consolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass